Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zymeworks (ZYME) Equity Ratio (2021 - 2025)

Zymeworks' Equity Ratio history spans 5 years, with the latest figure at 0.77 for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 5.92% to 0.77 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.77, a 5.92% increase, with the full-year FY2025 number at 0.77, up 5.92% from a year prior.
  • Equity Ratio hit 0.77 in Q4 2025 for Zymeworks, down from 0.81 in the prior quarter.
  • Over the last five years, Equity Ratio for ZYME hit a ceiling of 0.82 in Q2 2025 and a floor of 0.6 in Q3 2022.
  • Historically, Equity Ratio has averaged 0.75 across 5 years, with a median of 0.76 in 2025.
  • Biggest five-year swings in Equity Ratio: grew 27.4% in 2023 and later dropped 8.58% in 2024.
  • Tracing ZYME's Equity Ratio over 5 years: stood at 0.64 in 2021, then rose by 18.71% to 0.76 in 2022, then rose by 5.3% to 0.8 in 2023, then decreased by 8.58% to 0.73 in 2024, then grew by 5.92% to 0.77 in 2025.
  • Business Quant data shows Equity Ratio for ZYME at 0.77 in Q4 2025, 0.81 in Q3 2025, and 0.82 in Q2 2025.